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ABSTRACT 
Photodynamic therapy (PDT) is a treatment of cancer by which tumour cells are 
destroyed using reactive oxygen species produced by photosensitisers following 
activation with visible or near infrared light. Successful PDT depends on the solubility 
and the targeting ability of the photosensitisers. In this work, the synthesis of a 
porphyrin-based water soluble nanoparticle conjugate containing a targeting agent that 
recognises the erbB2 receptor overexpressed on the surface of particular cancer cells is 
reported. The nanoparticle conjugates were synthesised following two different 
protocols, viz. a biphasic and a monophasic method, with the aim to determine which 
method yielded the optimal nanosystem for potential PDT applications. The 
nanoparticles were characterised using UV-Vis absorption and fluorescence 
spectroscopies together with transmission electron microscopy and zeta potential 
measurements; and their ability to produce singlet oxygen following irradiation was 
investigated following the decay in absorption of a singlet oxygen probe. The 
nanoparticles synthesised using the monophasic method were shown to produce the 
highest amount of singlet oxygen and were further functionalised with anti-erbB2 
antibody to target the erbB2 receptors expressed on the surface of SK-BR-3 human 
breast cancer cells. The water soluble, antibody-porphyrin nanoparticle conjugates were 
shown to elicit targeted PDT of the breast cancer cells.  
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INTRODUCTION 
Photodynamic therapy (PDT) is an approach to cancer treatment based on the 
activation of photosensitiser drugs using visible or near infrared light to generate 
reactive oxygen species that induce cell death.1 Characteristics such as: a high 
absorption coefficient and high photostability are required for a photosensitiser drug.2 
Examples of photosensitisers reported as effective for PDT treatment of cancer include 
organic molecules such as porphyrins, phthalocyanines and related tetrapyrroles.3 One 
of the drawbacks of some of the reported photosensitisers when used as drugs for PDT 
is the non-specific distribution of the drug in the body, leading to possible side effects 
caused by the patient’s exposure to sun light.4 Furthermore, some of the currently used 
photosensitisers are hydrophobic molecules requiring their dispersion in emulsions or 
the use of delivery systems to administer the drugs. Such drawbacks of molecular 
photosensitisers for PDT can be overcome through the use of nanoparticles as drug 
delivery systems.5 Silica nanoparticles,6 polymeric nanoparticles,7 magnetic 
nanoparticles,5,7 quantum dots,8 upconverting nanoparticles9 and especially gold 
nanoparticles5 are emerging as ideal candidates for use as delivery vehicles of 
hydrophobic photosensitisers for PDT. In the field of gold nanoparticles (AuNPs), Brust 
and co-workers reported a method based on the use of tetraoctylammonium bromide as 
the phase transfer reagent for the synthesis of gold nanoparticles functionalised with 
hydrophobic ligands that were ultimately soluble in polar solvents.10 Following this 
method, Russell and co-workers reported phthalocyanine functionalised gold 
nanoparticles that were used for PDT of cancer and a higher production of singlet 
oxygen was observed for the bound photosensitiser when compared to the free drug.11,12 
Alternative procedures have been developed more recently for the synthesis of water 
soluble AuNPs functionalised with hydrophobic ligands.5 These new synthetic methods 
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rely on the multifunctionalisation of the gold core, for example, by incorporating water 
soluble polymers or polyethyleneglycol (PEG) ligands to increase the water solubility of 
the nanosystem. Gamaleia et al. achieved the water solubility of gold nanoparticles 
functionalised with the porphyrin derivative hematoporphyrin by adsorbing the 
photosensitiser within a layer of polyvinylpyrrolidone that was used to stabilise the 
nanoparticle.13 Another porphyrin derivative, protoporphyrin IX was reacted with a 
positively charged branched polyethyleneimine on the surface of gold nanoparticles 
yielding water stable nanostructures useful for PDT.14 Zaruba et al. attached two 
porphyrin-brucine conjugates to 3-mercaptopropanoic acid modified gold nanoparticles 
(ca. 14.7 nm) yielding two types of porphyrin-stabilised nanoparticles that could be 
dispersed in culture media and that were tested for PDT both in vitro and in vivo.15 
The use of PEG to provide water solubility to the nanoparticles has been applied by 
Burda and co-workers for the synthesis of gold nanoparticles containing a non-
covalently bound silicon phthalocyanine.16-19 PEG has also been used to provide water 
solubility and to enhance in vivo accumulation in the tumour tissue by the enhanced 
vascular permeability and retention effect of gold nanoparticles functionalised with a 
hydrophobic zinc phthalocyanine.20 Furthermore, PEG can also be a key building block 
in the synthesis of nanosystems for targeted photodynamic therapy. Cancer cells that 
overexpress specific cell surface receptors can be selectively recognised by 
incorporating the corresponding targeting agents such as antibodies or lectins onto the 
surface of the nanoparticles. These specific antibodies or lectins can be linked to PEG 
functionalised nanoparticles via amide bond formation between the terminal carboxylic 
group of the PEG-derivative ligand and the amine residues present in the proteins. 
Russell and co-workers have reported targeted PDT of breast cancer cells using 
PEGylated gold nanoparticles functionalised with a phthalocyanine derivative ligand 
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and the antibody anti-erbB2 that recognizes the membrane receptor erbB2.21 These 
authors have shown that the nanoparticle conjugates with the anti-erbB2 antibody 
selectively target the erbB2 receptor that is overexpressed on SK-BR-3 breast cancer 
cells while having limited or no targeted photoactivity for the MDA-MB-231 breast 
cancer cells (breast cancer cell line without erbB2 amplification) or normal mammary 
epithelial cells (MCF-10A). In addition, targeting of the T antigen on the surface of 
human colorectal adenocarcinoma cells has been achieved using the lectin Jacalin 
conjugated to phthalocyanine functionalised gold nanoparticles.22,23 
Amongst the photosensitisers reported as useful for PDT,3 porphyrins have been 
widely studied, especially since the development of the hematoporphyrin derivative, 
Photofrin®, that was first approved for the treatment of cancer in the 1990s and is 
currently used clinically.3 We have recently reported the synthesis of a hydrophilic 
porphyrin that, when used to functionalise iron oxide nanoparticles, had potential 
applications as an agent for PDT;24 and of water soluble gold nanoparticles 
functionalised with a thiolated porphyrin derivative and a thiolated PEG derivative that 
have demonstrated low intrinsic toxicity in vitro and are able to produce singlet oxygen 
in solution.25 Thus, the use of water soluble porphyrin-coated gold nanoparticles in 
combination with antibodies covalently immobilised onto the nanoparticle surface could 
present a promising photosensitiser conjugate for targeted PDT. 
Here, we report, to the best of our knowledge, the first multicomponent water soluble 
nanoparticle conjugate that combines the functionalisation of gold nanoparticles with a 
porphyrin derivative ligand, together with a PEG derivative ligand and an antibody 
targeting agent. First, gold nanoparticles functionalised with the porphyrin derivative 
containing an alkanethiol (5-[4-(11-mercaptoundecyloxy)phenyl]-10,15,20-
triphenylporphyrin, PR-SH) and a thiolated carboxyl terminated PEG (COOH-PEG-
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SH) were synthesised following two different protocols: 1) the biphasic method 
reported by Brust et al. using toluene and water;10 and 2) a monophasic method that 
uses a mixture of dimethylformamide (DMF) and tetrahydrofuran (THF) as the 
solvent.22 Both methods yielded water soluble nanoparticles (PR-AuNP-PEG, Figure 
S1) that were characterised by UV-Vis absorption spectroscopy, fluorescence 
spectroscopy, transmission electron microscopy and measuring their zeta potential. The 
photosensitiser surface coverage was investigated for both nanosystems to obtain the 
optimum water soluble functionalised nanoparticles potentially suitable for PDT. Since 
it was established that the nanoparticles PR-AuNP-PEG, produced via the monophasic 
method, contained more photosensitiser molecules on the nanoparticle surface and 
produced the highest amount of singlet oxygen, these nanoconjugates were chosen as 
the optimal nanosystem for potential PDT applications. An anti-erbB2 antibody to 
specifically target the erbB2 receptors overexpressed on the surface of SK-BR-3 breast 
cancer cells was incorporated onto the PR-AuNP-PEG (monophasic) yielding PR-
AuNP-PEG-Ab nanoparticles (Figure 1) that proved successful for the production of 
singlet oxygen and induced cell death of the SK-BR-3 breast cancer cell following PDT 
irradiation.  
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Figure 1. Schematic representation of the PR-AuNP-PEG-Ab conjugates: gold 
nanoparticles functionalised with the thiolated porphyrin derivative ligand (red) and the 
thiolated polyethylene glycol derivative ligand (black) bound to an anti-erbB2 antibody (green). 
8 
 
EXPERIMENTAL PROCEDURES 
Materials and methods 
Solvents: water, toluene, tetrahydrofuran (THF), N,N-dimethylformamide (DMF) 
methanol, propionic acid, ethyl acetate, hexane, distilled water, dichloromethane 
(DCM), chloroform, acetonitrile (ACN) and absolute ethanol were of analytical grade 
and used as received unless otherwise stated.  
Commercially available compounds: pyrrole, p-hydroxybenzaldehyde, 
benzaldehyde, S-(11-bromoundecyl) thioacetate, potassium carbonate, gold(III) chloride 
trihydrate (HAuCl4·3H2O), tetraoctylammonium bromide (TOAB), sodium borohydride 
(NaBH4), N-hydroxysuccinimide (NHS), N-ethyl-N′-(3-dimethylaminopropyl) 
carbodiimide (EDC), 2-(N-morpholino)ethanesulfonic acid (MES) hydrate, propidium 
iodide and Tween 20 were purchased from Sigma-Aldrich, UK. α-Thio-ω-carboxy 
poly(ethylene glycol) 3073 Da (COOH-PEG-SH) was purchased from Iris Biotech 
GmbH. Anti-ErbB 2 antibody [ICR55] was purchased from Abcam, UK. 9,10-
anthracenedipropionic acid (ADPA) was purchased from Molecular Probes. Sodium 
dihydrogen orthophosphate dihydrate (NaH2PO4·2H2O), di-sodium hydrogen 
orthophosphate anhydrous (Na2HPO4), sodium chloride (NaCl), phosphate buffered 
saline (PBS) tablets, foetal bovine serum, 75 cm3 Nunc Easy tissue culture flasks with 
porous caps, Nunc multidishes and 18 mm diameter glass coverslips were purchased 
from Thermo Fisher Scientific, UK. Sodium hydrogen carbonate (NaHCO3) was 
purchased from BDH Laboratory Supplies Poole, UK. Trypsin 0.25 % (1x) with 
ethylenediaminetetraacetic acid (EDTA), L-glutamine and McCOY’s 5A medium were 
purchased from Invitrogen, UK. Millex GP syringe driven filter units (0.22 µm) were 
purchased from Millipore Corporation, USA. Sterile centrifuge tubes and sterile 
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disposable serological pipettes, individually wrapped, were purchased from Corning B. 
V. Life Sciences (The Netherlands). VivaspinTM 500 µL columns (100 KDa molecular 
weight cut off, with polyethersulfone membrane) were purchased from Sartorius 
Biotech, UK. 
SK-BR-3 human breast adenocarcinoma cells were purchased from LGC Standards. 
The SK-BR-3 cell line was kindly provided by Prof Dylan R. Edwards (School of 
Biological Sciences, University of East Anglia, UK). 
 
Instrumental techniques 
UV-Vis absorption spectra were recorded using a Hitachi U-3000 spectrophotometer, 
using quartz cuvettes with a 1 cm path length. Fluorescence excitation and emission 
spectra were recorded using a Hitachi F-4500 fluorescence spectrometer. The 
fluorescence excitation and emission spectra were recorded using quartz cuvettes with a 
1 cm path length. Transmission electron microscopy (TEM) images were obtained using 
a Jeol 2000EX TEM operating at 200 kV. Samples (5 µL) were deposited on a holey 
carbon film 300 mesh copper grids from Agar Scientific, UK. Zeta potential 
measurements were recorded using a Malvern Zetasizer Nano-ZS. Centrifugation of the 
nanoparticles was performed using a Beckman Coulter AllegraTM X-22R centrifuge. 
SK-BR-3 cells were imaged using a Zeiss Axiovert 200M microscope. Fluorescence 
images were captured using a 63x PlanApochromat (1.4 NA) oil-immersion objective 
lens, a Zeiss AxioCam MRm CCD camera and AxioVision software. Images collected 
were processed using the AxioVision SE64 Rel. 4.8 software.  
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Synthetic protocols 
Synthesis of the thiolated porphyrin derivative ligand PR-SH 
The thiolated porphyrin derivative ligand, 5-[4-(11-mercaptoundecyloxy)phenyl]-
10,15,20-triphenylporphyrin (PR-SH) was synthesised following a protocol recently 
reported by our group.25 
Synthesis of the water soluble functionalised nanoparticles (PR-AuNP-PEG) 
Method A: This method was based on a protocol previously reported by Brust et al.10 
A solution of HAuCl4·3H2O (3.6 mg, 9.14 µmol) in water (0.5 mL) was added to a 
stirred solution of tetraoctylammonium bromide (11 mg, 20.14 µmol) in toluene (1 mL). 
PR-SH (2 mg, 2.44 µmol) and COOH-PEG-SH (7.5 mg, 2.44 µmol) were dissolved in 
toluene (0.5 mL) and the solution was then added to the aqueous gold solution. An 
excess of NaBH4 (5.3 mg, 0.14 mmol) in water (1 mL) was added dropwise to the 
mixture. The mixture was reacted overnight under continuous stirring at room 
temperature. The aqueous phase of the resulting dark red solution was separated from 
the organic phase using an extraction funnel. The water was removed by rotary 
evaporation and the solid was washed with ethanol (3 x 5 mL) using centrifugation 
(13,000 rpm, 30 min). The resulting PR-AuNP-PEG (biphasic) were stored at 4 °C in 
MES buffer (50 mM, pH 5.5, 0.05% Tween 20).  
Method B: This method was based on a protocol previously reported by Obaid et 
al.22 PR-SH (1 mg, 1.22 µmol) was dissolved in dry THF (0.5 mL) and was added to a 
stirred solution of the COOH-PEG-SH (3.75 mg, 1.22 µmol) in dry THF (1 mL). After 
5 min, a solution of HAuCl4·3H2O (0.6 mg, 1.52 µmol) in dry DMF (0.6 mL) was 
added. The reaction was stirred for 5 min and a fresh solution of NaBH4 (0.75 mg, 19.8 
µmol) in DMF (0.6 mL) was rapidly added. The reaction was stirred overnight at room 
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temperature. Next, THF (4 mL) was added and the solution was centrifuged (5,000 rpm, 
2 min). The gold nanoparticles functionalised with both ligands, PR-SH and COOH-
PEG-SH, remained stable in the THF while any gold nanoparticles not functionalised 
with the PR-SH ligand precipitated. The supernatant was collected and the solvent was 
removed by rotary evaporation. THF (4 mL) was added and the solution was 
centrifuged (5,000 rpm, 2 min) to remove the gold nanoparticles non-functionalised 
with PR-SH, which stay in the pellet. The supernatant was collected and the solvent 
evaporated by rotary evaporation. The solid obtained was dissolved in 5 mL of MES 
buffer (50 mM, pH 5.5, 0.05% Tween 20). Finally, the solution was centrifuged (13,000 
rpm, 30 min) and the supernatant containing the PR-AuNP-PEG (monophasic) were 
stored at 4 °C.  
Synthesis of the non-water soluble porphyrin functionalised nanoparticles (PR-AuNP) 
A solution of HAuCl4·3H2O (3 mg, 7.6 µmol) in water (5 mL) was added to a stirred 
solution of tetraoctylammonium bromide (7.6 mg, 13.8 µmol) in toluene (5 mL). PR-
SH (5 mg, 6.1 µmol) was dissolved in toluene (1.5 mL) and added to the biphasic 
solution. An excess of NaBH4 (5.3 mg, 0.140 mmol) in water (1 mL) was slowly added 
to the mixture. The reaction was stirred at room temperature overnight. The organic 
phase of the resulting dark red solution was separated using an extraction funnel and 
then the solvent was removed by rotary evaporation. The solid sample was washed with 
ethanol (3 x 5 mL), which each washing removed by centrifugation (13,000 rpm, 30 
min) to give PR-AuNP as a red solid that was soluble in DCM or DMSO. 
Synthesis of the antibody functionalised nanoparticles (PR-AuNP-PEG-Ab) 
N-ethyl-N′-(3-dimethylaminopropyl) carbodiimide (EDC, 0.4 µL, 2.25 µmol) and N-
hydroxysuccinimide (NHS, 1.5 mg, 13 µmol) were added to 1 mL of the PR-AuNP-
PEG (monophasic) solution and the mixture was stirred at room temperature for 30 
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min. Excess EDC and NHS were removed by centrifugation (14,000 rpm for 30 min at 
4 °C) using VivaspinTM 500 µL columns. The nanoparticles were resuspended in PBS 
buffer (1 mL, pH 7.4) and anti-ErbB2 antibody (18 µL, 1 mg/mL) was added. The 
mixture was stirred slowly for 15 h at room temperature. Finally, the unbound antibody 
was removed from the nanoparticle solution by five repeated filtrations of the sample in 
VivaspinTM 500 µL columns (14,000 rpm, 30 min at 4 °C). After each centrifugation, 
the nanoparticles were resuspended in 500 µL of PBS, yielding PR-AuNP-PEG-Ab 
that were kept in sterilised PBS at 4 °C.  
 
Singlet oxygen production 
ADPA reacts with singlet oxygen to give an endoperoxide, the formation of which 
can be observed by UV-Vis absorption spectroscopy.26 ADPA (50 µL of a 1.1 mM 
solution in methanol) was added to 550 µL of the PR-SH in DCM, PR-AuNP in 
DMSO, and PR-AuNP-PEG (biphasic), PR-AuNP-PEG (monophasic) and PR-
AuNP-PEG-Ab in PBS buffer. The solutions were added to a quartz cuvette and stirred 
thoroughly. A blue light source, with a wavelength range between 400 and 500 nm, was 
used to irradiate the solutions during 4 h under stirring. An UV-Vis absorption spectrum 
between 300 and 700 nm of each sample was recorded every hour, and the singlet 
oxygen production was determined by the decrease of the absorption intensity at 378 
nm of the ADPA. 
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Biological experiments 
Imaging medium 
The imaging medium based on Hank’s balanced salt solution (HBSS) was prepared 
in water containing NaCl (120 mM), KCl (5 mM), CaCl2 (2 mM), MgCl2 (1 mM), 
NaH2PO4·2H2O (1 mM), NaHCO3 (1 mM) and 4-(2-hydroxyethyl)piperazine-4-
ethanesulfonic acid (HEPES, 25 mM). The pH of the imaging medium was adjusted to 
pH 7.2 using aqueous solutions of NaOH and HCl (0.01 – 1.00 M). The imaging 
medium was supplemented with bovine serum albumin (1 mg/mL), basal medium eagle 
amino acids (2%), glutamine (2 mM) and glucose (11 mM). The imaging medium was 
sterilised by filtration through a Millex GP syringe driven filter unit (0.22 µm) prior to 
use.  
Phosphate buffer saline (PBS) 
The phosphate buffered saline solution used for the cell-based experiments was 
prepared by dissolving 10 PBS tablets in water (1 L). This solution was sterilised by 
autoclaving at 110 °C for 10 min. The as-prepared PBS solutions contained Na2HPO4 (8 
mM), KH2PO4 (1 mM), NaCl (160 mM), and KCl (3 mM); and had a pH value of 7.3.  
The PBS buffer (10 mM) used to dissolve the propidium iodide was prepared using 
NaH2PO4·2H2O and Na2HPO4 stock solutions (200 mM). The as-prepared PBS 
solutions contained NaCl (150 mM) and calcium chloride dihydrate (100 µM). The pH 
of the PBS was adjusted to pH 7.4 using aqueous solutions of NaOH and HCl (0.01 – 
1.00 M). The buffer was sterilised by filtration through a Millex GP syringe driven filter 
unit (0.22 µm) prior to use.  
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SK-BR-3 cell culture 
SK-BR-3 human breast adenocarcinoma cells were cultured in McCOY’s 5A 
medium supplemented with 10% foetal bovine serum and 1.5% L-glutamine (200 mM). 
The cells were routinely cultured at 37 °C in a 5% CO2 atmosphere in 75 cm
3 Nunc 
Easy tissue culture flasks with porous caps. Subcultures (1:6) were made every 5 days 
by washing the cells with PBS and dislodging the cells from the flask surface using 
trypsin 0.25% (1x) EDTA. 
Culture of SK-BR-3 cells onto coverslips 
For imaging, SK-BR-3 cells were cultured on 18 mm diameter glass coverslips 22 – 
24 h prior to performing imaging experiments. Cells were cultured at 37 °C in a 5% 
CO2 atmosphere in a 75 cm
3 tissue culture flask until they reached near confluence. 
Cells were washed with PBS and harvested from the flask using trypsin as indicated 
previously. A sterile coverslip was placed in each well of a 6-well Nunc multidish. 
Supplemented McCOY’s medium (2 mL) and an aliquot of the cell suspension (1 mL) 
were added to each well covering the coverslip. The cells were then incubated at 37 °C 
in a 5% CO2 atmosphere for 22 – 24 h. 
Incubation of SK-BR-3 cells with PR-AuNP-PEG-Ab 
The growth medium in the well containing the coverslip with the SK-BR-3 cells of 
interest was removed using a pipette. The cells were washed once with PBS (1 mL) and 
incubated for 3 h at 37 °C in a 5% CO2 atmosphere in McCOY’s medium supplemented 
only with L-glutamine (1.5 mM) containing PR-AuNP-PEG-Ab (0.8 µM porphyrin 
equivalent).  
SK-BR-3 control cells were grown in a similar manner but without the PR-AuNP-
PEG-Ab conjugates. 
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Incubation of SK-BR-3 with propidium iodide 
Propidium iodide (5 µL, 1 mg/mL in PBS) was mixed with HBSS-based imaging 
medium (1 mL), this was added to stain the SK-BR-3 cells on the coverslip and 
incubated in the dark at 37 °C.  
Imaging and irradiation of SK-BR-3 cells loaded with and without PR-AuNP-PEG-Ab  
For imaging, 18-mm cover slips containing the SK-BR-3 cells were placed in a 
Ludin chamber (Life Imaging Service, Olten, Switzerland) which was securely 
tightened. Each coverslip was washed three times with HBSS-based imaging medium 
and the Ludin chamber was mounted on a stage at 37 °C in a Zeiss Axiovert 200M 
microscope. The images were acquired with a 63x PlanApochromat (1.4 NA) oil-
immersion objective. The PR-AuNP-PEG-Ab uptaken by the cells were excited at 530 
– 585 nm and the fluorescence emission was collected through a 600 nm long-pass 
filter. To activate the generation of singlet oxygen by the PR-AuNP-PEG-Ab within 
the cells, the cells were illuminated through the objective with the light from a mercury 
arc lamp reflected off a long-pass, dichroic mirror with a cut-off of 495 nm for 30 s.  
Imaging of SK-BR-3 cells loaded with propidium iodide 
The propidium iodide stained the nucleus of dead cells with significant membrane 
damage. Fluorescence from the propidium iodide was excited at 530-585 nm and the 
fluorescence emission collected through a 600 nm long-pass filter. 
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RESULTS AND DISCUSSION 
Synthesis of the functionalised nanoparticles: PR-AuNP-PEG and PR-
AuNP 
The synthesis of the thiolated porphyrin derivative ligand, 5-[4-(11-
mercaptoundecyloxy)phenyl]-10,15,20-triphenylporphyrin (PR-SH), was accomplished 
following a previously reported protocol.25 The ligand PR-SH was used, together with 
the α-thio-ω-carboxy-polyethylene glycol derivative ligand (COOH-PEG-SH) for the 
functionalisation of gold nanoparticles. Both ligands are suitable to functionalise gold 
nanoparticles through the presence of the thiol groups. The function of the porphyrin 
derivative on the nanoparticles is to act as the photosensitiser to produce singlet oxygen. 
The PEG derivative ligand has a double function: 1) to increase the water solubility of 
the nanoparticles and 2) to immobilise the targeting antibody anti-erbB2 through the 
terminal carboxylic group. The functionalisation of the AuNP with PR-SH and with 
COOH-PEG-SH to generate PR-AuNP-PEG was achieved following two different 
approaches: 
- In Method A, based on the biphasic method previously described by Brust et al.,10 
PR-SH was dissolved in toluene and mixed with COOH-PEG-SH and the 
metallic gold precursor (HAuCl4) dissolved in water. Tetraoctylammonium 
bromide (TOAB) was added as the phase transfer agent and NaBH4 as the 
reducing agent, and the mixture was reacted overnight to obtain the water soluble 
PR-AuNP-PEG (biphasic) nanoparticles (Figure S1). 
- In Method B, based on a monophasic method,22 the reaction occurs only in one 
phase since PR-SH and COOH-PEG-SH are both dissolved in THF and mixed 
with a solution of HAuCl4 in DMF to which a solution of NaBH4 also in DMF is 
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added. THF and DMF are miscible solvents providing a unique reaction phase. 
The mixture was left stirring overnight to obtain the water soluble PR-AuNP-
PEG (monophasic) nanoparticles (Figure S1). 
The properties of the nanoparticles obtained following both methods were compared in 
order to determine the optimal nanoparticles in terms of size, distribution, 
photosensitiser coverage and ability to produce singlet oxygen. 
Additionally, gold nanoparticles coated only with the porphyrin derivative ligand 
PR-SH (PR-AuNP – Figure S2) were synthesised using the biphasic method and were 
soluble in DCM and DMSO, and their properties were compared with those of the PR-
AuNP-PEG nanoparticles.  
Noticeably, the method of synthesis has a clear influence not only on the size of the 
formed nanoparticles but, importantly, on their chemical composition (see later). This 
could be the result of two aspects which are worth noting: a) The amount of PR-SH 
varies according to the methodology used, since less porphyrin (relative to gold) is used 
for the biphasic synthesis; thus, the ratio  Au:PR-SH for PR-AuNP-PEG (monophasic) 
is 1:1, whereas for PR-AuNP-PEG (biphasic) is 3.7:1, and for PR-AuNP is 1.2:1. b) 
The biphasic methodology follows different kinetics, since it involves initial 
encapsulation, phase transfer and stabilization of the gold by the surfactant TOAB, 
followed by surface exchange with a thiol ligand (e.g. PR-SH), whereas the 
monophasic system allows direct linkage of the thiolated species to the growing gold 
surface of the nanoparticle. 
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Characterisation of the functionalised nanoparticles. 
UV-Vis extinction spectroscopy 
UV-Vis extinction spectroscopy was used to characterise the different synthesised 
gold nanoparticles and to confirm their functionalisation with the porphyrin derivative 
ligand PR-SH (Figure 2). The UV-Vis absorption spectrum of the free ligand PR-SH 
exhibited the Soret band at  = 422 nm and the four Q bands between 500 and 700 nm 
characteristic of metal free porphyrin derivatives.27 The characteristic Soret band was 
also observed in the UV-Vis extinction spectra of the synthesised nanoparticles, PR-
AuNP and PR-AuNP-PEG, albeit slightly shifted from that of the free ligand, at ca. 
419 nm for PR-AuNP, 425 nm for PR-AuNP-PEG (monophasic) and 429 nm for PR-
AuNP-PEG (biphasic), respectively. The presence of the Soret band in the UV-Vis 
extinction spectrum of the nanoparticles confirmed the functionalisation of the gold core 
with the porphyrin derivative ligand for all of the nanoparticles synthesised. The slight 
red-shift in the position of this characteristic absorption band of the porphyrin could be 
attributed to the different environment in which PR-SH ligand is found when attached 
to the gold nanoparticles, indicating the formation of a weakly coupled J-aggregate.  
The UV-Vis extinction spectra of PR-AuNP-PEG (monophasic) and PR-AuNP also 
exhibited the characteristic four Q bands of the porphyrin between 500 and 700 nm 
although the absorption bands were broader and less intense than those observed in the 
UV-Vis absorption spectrum of the free PR-SH.  
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Figure 2. UV-Vis extinction spectrum of the free PR-SH (2.04·10-4 mg/mL, black) and PR-
AuNP (0.4 mg/mL, red) in DCM; PR-AuNP-PEG (biphasic) (green) and PR-AuNP-PEG 
(monophasic) (blue) in MES buffer (0.4 mg/mL). Inset: Magnification of the Q band region 
from 500 to 700 nm. 
 
Transmission electron microscopy 
The functionalised nanoparticles were characterised using transmission electron 
microscopy (TEM) to determine their morphology, polydispersity and size (Figure 3). 
The PR-AuNP-PEG nanoparticles were spherical in shape with low polydispersity and 
uniform size distribution with mean diameters of ca. 4.5 nm and 9 nm, for the biphasic 
and monophasic synthetic methods, respectively, as shown in the histograms of Figure 
3b and 3d. These results show that the functionalised nanoparticles synthesised using 
the biphasic method were smaller than those synthesised using the monophasic method 
with a mixture of DMF/THF as the solvent. PR-AuNP, synthesised using the biphasic 
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method had, as expected, a similar size (diameter ca. 5 nm) and shape than the PR-
AuNP-PEG (biphasic) (Figure S3).  
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Figure 3. Transmission electron micrographs (a and c) and size distribution histograms (b 
and d) of: a and b) PR-AuNP-PEG (biphasic) (n = 298) and c and d) PR-AuNP-PEG 
(monophasic) (n = 172). Scale bars: 20 nm. 
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Quantification of the porphyrin derivative ligand on the surface of 
the nanoparticles 
Quantifying the amount of photosensitiser molecules that are self-assembled on the 
surface of the AuNPs is relevant since this concentration would be related to the 
quantity of singlet oxygen that the functionalised nanoparticles can produce. The 
number of PR-SH molecules immobilised on the surface of AuNPs can be estimated by 
UV-Vis absorption spectroscopy using the absorption intensity of its Soret band. First, a 
calibration curve using known concentrations of PR-SH in DCM solution (from 0.5 to 
15 µM) was obtained (Figure S4). From the calibration curve, the extinction coefficient 
of PR-SH was estimated to be Ԑ418nm = 3.75x104 M-1·cm-1. Applying the Beer-Lambert 
law and the calibration curve given in Figure S4, the concentration of the PR-SH 
immobilised on the different synthesised gold nanoparticles can be estimated. To 
eliminate the contribution of the gold nanoparticles to the UV-Vis extinction spectrum 
of the functionalised nanoparticles, the extinction at 460 nm (contribution of the 
AuNPs) was subtracted from the corresponding Soret band of the porphyrin (ca. 430 
nm, 426 nm and 418 nm for PR-AuNP-PEG (biphasic), PR-AuNP-PEG (monophasic) 
and PR-AuNPs, respectively) as indicated in Figure S5. Concentrations of PR-SH of 
2.55 µM, 16.65 µM and 41.43 µM were estimated for PR-AuNP-PEG (biphasic), PR-
AuNP-PEG (monophasic) and PR-AuNPs, respectively (see Figure S6 for 
calculations). These results indicate that PR-AuNP-PEG synthesised using the 
monophasic method have a considerably larger concentration of porphyrin molecules on 
the particle surface than the PR-AuNP-PEG (biphasic). As expected, the highest 
number of porphyrin molecules were present on the surface of the PR-AuNPs.  
Once the concentration of PR-SH for each type of nanoparticles and their respective 
diameters are known, the ratios of porphyrin per nanoparticle can be estimated using the 
22 
 
calculations reported by Haiss et al.28 The ratio of porphyrin per nanoparticle was 
determined to be 56 for PR-AuNP-PEG (biphasic) and 3882 for PR-AuNP-PEG 
(monophasic) (Table 1). These results clearly show that using the monophasic synthesis 
methodology the quantity of immobilised PR-SH was ca. 69 times higher than when 
the biphasic methodology was used. The same approach was followed to calculate the 
ratio of porphyrin/AuNPs on the non-water soluble PR-AuNPs, obtaining 678 
porphyrins per nanoparticle (Table 1). The ratio of porphyrin present per nm2 of 
nanoparticle was calculated using the corresponding estimated porphyrin/AuNP ratios 
and calculating the area of each type of spherical surface AuNPs (Table 1). The number 
of porphyrin molecules per nm2 was estimated to be 15.26 for PR-AuNP-PEG 
(monophasic), 0.88 for PR-AuNP-PEG (biphasic), and 8.64 for PR-AuNP.   
These results confirm that the methodology of synthesis is crucial for the size and 
composition of the AuNPs. One phase synthesis, which uses a ratio of PR-SH relative 
to gold (1:1) and a different diffusion and coating kinetics in the continuous phase, leads 
to functionalised particles that are bigger (diameter ca. 9 nm) and have a higher content 
of PR-SH (Table 1). Two phase synthesis gives smaller nanoparticles (ca. 5 nm 
diameter) and less enriched in PR-SH, especially for PR-AuNP-PEG (biphasic), where 
two thiol ligands (PR-SH and COOH-PEG-SH) compete for the gold surface. 
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Table 1. Estimated values of: 1) the concentration of immobilised PR-SH, 2) the number of 
molecules of PR-SH per AuNP, 3) diameter of the different types of AuNPs (nm), 4) the 
surface area per AuNP, and 5) the ratio porphyrin derivative ligand per AuNP. 
 
 
Immobilised 
PR-SH 
Ratio 
PR-SH /AuNP 
AuNP diameter 
(nm)a 
AuNP area 
(nm2) 
Ratio 
PR-SH /AuNP 
area (nm2)b 
PR-AuNP-PEG 
(biphasic) 
2.55 µM 56 4.5 63.6 0.88 
PR-AuNP-PEG 
(monophasic) 
16.65 µM 3882 9 254.4 15.26 
PR-AuNP 41.43 µM 678 5 78.5 8.64 
aMeasured by TEM. bNumber of PR-SH molecules per nm2 of nanoparticle surface. 
 
Fluorescence spectroscopy 
The porphyrin functionalised gold nanoparticles were further characterised using 
fluorescence spectroscopy. Figure 4 shows the fluorescence emission spectra of the free 
ligand PR-SH and of the different porphyrin functionalised gold nanoparticles in 
solution. The fluorescence emission spectrum of the free PR-SH exhibits two emission 
bands at  ca. 650 and 712 nm that are characteristic of porphyrin derivatives.27 The 
two characteristic bands were also observed for the PR-AuNP-PEG (monophasic) and 
for PR-AuNP; however, they were not present in the fluorescence emission spectrum of 
the PR-AuNP-PEG (biphasic) possibly due to the low concentration of PR-SH on the 
surface of these nanoparticles. The fluorescence excitation spectra of the free ligand 
PR-SH and of the functionalised nanoparticles were also obtained (Figure S7). Again, 
the characteristic porphyrin excitation spectrum was only observed for the PR-SH, PR-
AuNP-PEG (monophasic) and PR-AuNP.  
 
24 
 
650 700 750 800
0
100
200
300
400
500
600
 
 
F
lu
o
re
s
c
e
n
c
e
 E
m
is
s
io
n
 /
 a
.u
.
Wavelength / nm
 
Figure 4. Fluorescence emission spectra (excitation at  = 591 nm) of: PR-SH (2.04·10-4 
mg/mL in DCM – black), PR-AuNP-PEG (biphasic) (0.4 mg/mL in water – green), PR-AuNP-
PEG (monophasic) (0.4 mg/mL in water – blue) and PR-AuNP (0.4 mg/mL in DCM – red). 
The spectrum of the free ligand PR-SH was recorded using ex/em slits = 5 while the spectra of 
the porphyrin functionalised gold nanoparticles were recorded using ex/em slits = 10. 
 
The different techniques used to characterise the porphyrin functionalised gold 
nanoparticles confirmed that the PR-AuNP-PEG (monophasic) incorporated a larger 
number of the PR-SH ligands on the nanoparticle’s surface than those produced using 
the biphasic synthetic method. Also, PR-AuNPs incorporate a high number of PR-SH; 
however, they are not water soluble and they do not have any functional moieties to 
enable the incorporation of an antibody onto the nanostructure. PR-AuNP-PEG contain 
terminal carboxylic acid groups, at the end of the PEG ligand, capable of forming 
covalent bonds with biomolecules such as antibodies. Therefore, the water soluble PR-
AuNP-PEG (monophasic) were chosen as the more promising nanoparticles for the 
production of singlet oxygen and the incorporation of targeting antibodies.  
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Antibody anti-erbB2 immobilisation: synthesis and characterization of 
PR-AuNP-PEG-Ab conjugates  
To achieve an active targeting of cancer cells, anti-erbB2 antibodies were 
immobilised on the surface of the PR-AuNP-PEG (monophasic) since these water 
soluble nanoparticles contained the highest concentration of photosensitiser molecules. 
The antibody anti-erbB2 was chosen since it recognizes selectively the erbB2 receptors 
that are overexpressed on the cellular surface of ca. 25% of breast cancers.29 The 
antibody anti-erbB2 was linked to the terminal carboxylic groups of the PEG ligands as 
shown in Figure 1. The carboxylic groups of the PEG ligands were first activated by 
EDC/NHS chemistry to form stable amide bonds with the antibody yielding PR-AuNP-
PEG-Ab conjugates. The UV-Vis extinction spectrum of the PR-AuNP-PEG-Ab 
conjugates exhibited the characteristic bands of the porphyrin derivative ligand and a 
band at ca. 280 nm characteristic of the protein structure30 (Figure S8), thus confirming 
the functionalisation of the nanoparticles with the anti-erbB2 antibody. 
The charge on the surface of the synthesised nanoparticles, which depends on the 
coating surrounding the nanocore, was analysed by measuring the zeta potential of the 
different samples (Table S1). Both PR-AuNP-PEG nanoparticles, biphasic and 
monophasic, have a negative zeta potential since the terminal carboxylic groups of the 
PEG ligands are negatively charged at neutral pH (PBS, pH 7.4). The difference in the 
zeta potential value between the PR-AuNP-PEG (biphasic) (-21.96 mV) and PR-
AuNP-PEG (monophasic) (-11.76 mV) suggests that the former are coated with a 
greater amount of PEG ligands. Following immobilisation of the antibody, the zeta 
potential of the PR-AuNP-PEG (monophasic) increased to 0.04 mV. This could be due 
to the formation of amide bonds between the terminal carboxylic group in the PEG 
ligands and the amines in the anti-erbB2 antibodies.  
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Singlet oxygen production 
The ability of the free ligand PR-SH and of the functionalised nanoparticles to 
produce singlet oxygen was investigated. The different samples were irradiated during 4 
h with a blue light source ( = 400-500 nm) in the presence of 9,10-
anthracenedipropionic acid (ADPA), a singlet oxygen probe. ADPA undergoes a 
continuous photobleaching in the presence of singlet oxygen due to the formation of an 
endoperoxide.26 The formation of the endoperoxide can be followed by measuring the 
UV-Vis absorption decay of the ADPA upon irradiation.  
The photobleaching of the ADPA upon irradiation of PR-SH and of the PR-AuNP 
with a blue light source is shown in Figure S9 (a and b, respectively). These 
experiments were performed in DCM since both PR-SH and PR-AuNP are not water 
soluble. The absorption band observed at ca. 420 nm corresponds to the Soret band of 
the porphyrin derivative whereas the bands at ca. 400, 378, 360 and 340 nm correspond 
to the characteristic absorbance profile of the ADPA molecule. The decay of the ADPA 
absorption was observed for both samples, indicating the formation of the endoperoxide 
and therefore, the production of singlet oxygen. A decrease in the Soret band was also 
observed for the PR-AuNP, possibly due to partial decomposition of the porphyrin 
during the formation of the singlet oxygen.  
Figure S9 (c and d) show the time-dependent decay of the ADPA absorption 
spectrum following irradiation of the water dispersible nanoparticles PR-AuNP-PEG 
(biphasic) and PR-AuNP-PEG (monophasic), respectively. It was observed that the 
decay of the absorption of ADPA was higher for the PR-AuNP-PEG (monophasic) 
than for the PR-AuNP-PEG (biphasic), as expected due to the higher concentration of 
porphyrin derivative ligand on the nanoparticle’s surface. No significant changes were 
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observed with the Soret band of these two types of functionalised nanoparticles. The 
same experiment was performed with the PR-AuNP-PEG-Ab conjugates to investigate 
whether the presence of the antibody had any effect on the singlet oxygen production 
(Figure S9e). Photobleaching of ADPA was also observed when the PR-AuNP-PEG-
Ab conjugates were irradiated for 4 hours, thus confirming the production of singlet 
oxygen by the antibody functionalised nanoparticles. 
A summary of the progressive decay of the ADPA absorption band at  = 378 nm 
upon irradiation of the free porphyrin PR-SH and the four different porphyrin 
functionalised gold nanoparticles is shown in Figure S10, indicating the percentage of 
the ADPA that had been converted to the endoperoxide. After 4 hours following 
irradiation of the samples, the levels of ADPA decay for PR-SH, PR-AuNP, PR-
AuNP-PEG (monophasic) and PR-AuNP-PEG-Ab were 43%, 20%, 24% and 14%, 
respectively. These results indicate that these four samples produce singlet oxygen 
following irradiation. However, the ADPA decay upon irradiation of PR-AuNP-PEG 
(biphasic) was just 2% indicating a low singlet oxygen production by these 
functionalised nanoparticles. This latter result was to be expected with the low 
concentration of photosensitiser on the nanoparticle’s surface.  
To be able to compare the singlet oxygen production of the different samples, the 
maximum rate of ADPA photobleaching was normalised using the corresponding 
concentration of the photosensitiser and following Equation 1.  
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Equation 1. Equation used to calculate the maximum rate of ADPA photobleaching. 
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The calculated % rates of ADPA photobleaching for the five analysed samples are 
shown in Figure 5. PR-AuNP-PEG (monophasic) (% rate of ADPA photobleaching of 
5.5% Abs/(min·mM)) produce singlet oxygen in a more efficient manner than PR-
AuNP-PEG (biphasic) (2.1% Abs/(min·mM)). These results confirm that the 
nanoparticles containing more porphyrin derivative ligands per nanoparticle (PR-
AuNP-PEG (monophasic)) produce a greater amount of singlet oxygen. The calculated 
% rate of ADPA photobleaching for PR-SH was 1.6% Abs/(min·mM), while the PR-
AuNP showed the highest % rate of ADPA photobleaching (9% Abs/(min·mM)). This 
last observation also clearly indicates the enhancement in singlet oxygen production 
induced by the immobilisation of PRSH onto the nanoparticles. The % rate of ADPA 
photobleaching for PR-AuNP-PEG-Ab conjugates, 2.3% Abs/(min·mM), was a similar 
result to that of PR-AuNP-PEG (monophasic). Overall, these results demonstrate that: 
1) when the porphyrin is immobilised onto the surface of the gold nanoparticles, singlet 
oxygen is produced, 2) the % rate of ADPA photobleaching achieved is proportional to 
the amount of porphyrin on the nanoparticles, 3) the solvent has a pronounced influence 
on the singlet oxygen quantification, probably due to the reduced lifetime of singlet 
oxygen in aqueous solutions as compared to that found in organic solvents,31 and 4) the 
presence of the antibody appears to affect slightly the singlet oxygen production of the 
porphyrin functionalised nanoparticles, making PR-AuNP-PEG-Ab moderately less 
efficient. However, the variation in singlet oxygen production in the presence of the 
antibody is small.   
Although PR-AuNP showed the highest % ADPA photobleaching, PR-AuNP-PEG 
(monophasic) provide a nanoparticle formulation suitable for the incorporation of the 
anti-erbB2 antibody giving PR-AuNP-PEG-Ab that are still active for single oxygen 
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production and at the same time should be target selective, providing the best candidate 
for in vitro PDT experiments.  
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Figure 5. Percentage rate of ADPA photobleaching of the porphyrin derivative ligand PR-
SH and of the four different functionalised gold nanoparticles calculated based on the 
concentration of photosensitiser on the particles.  
 
In vitro PDT experiments using SK-BR-3 breast cancer cells 
To determine the suitability of the PR-AuNP-PEG-Ab conjugates for PDT, in vitro 
studies using a SK-BR-3 breast cancer cell line were performed. SK-BR-3 cells were 
used since they overexpress the membrane receptor erbB2 that can be specifically 
targeted by the antibody on the particles. The SK-BR-3 cells were incubated on glass 
coverslips with PR-AuNP-PEG-Ab conjugates (0.8 µM porphyrin equivalent) for 3 h. 
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Following incubation, the coverslips containing the SK-BR-3 cells were washed to 
remove any excess PR-AuNP-PEG-Ab and placed in a Ludin chamber at 37 °C in a 
fluorescence microscope. Since the porphyrin based ligands are fluorescent, it is 
possible to visualise the uptake of the PR-AuNP-PEG-Ab conjugates by the cells using 
fluorescence microscopy. Figure 6 shows images of the SK-BR-3 cells that had been 
incubated with the PR-AuNP-PEG-Ab conjugates. Control cells with no nanoparticles 
loaded were also imaged and are shown in Figure 6. These images, in particular the 
comparison between Figure 6 (b and e), clearly demonstrate the high level of cellular 
uptake of the PR-AuNP-PEG-Ab conjugates by the breast cancer cell line. The intense 
red fluorescence emission observed inside the cells treated with PR-AuNP-PEG-Ab 
conjugates (Figure 6b) was not observed in the control cells (Figure 6e).  
 
a) b) c)
d) e) f)
 
Figure 6. Bright field and fluorescence images of SK-BR-3 cells before irradiation to 
produce singlet oxygen: a – c) cells loaded with PR-AuNP-PEG-Ab conjugates and d – f) 
control cells without nanoparticles loaded. Images correspond to: bright field images (a and d); 
fluorescence images due to the fluorescence of the porphyrin on the nanoparticles (b and e) and 
composite images of bright field and fluorescence (c and f). Scale bars = 20 µm. 
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To activate the generation of singlet oxygen, SK-BR-3 cells loaded with the PR-
AuNP-PEG-Ab conjugates were irradiated with the light from a mercury arc lamp for 
30 s. Following irradiation of the cells, propidium iodide was added to stain the dead 
cells.32 When cells loaded with the PR-AuNP-PEG-Ab conjugates were irradiated to 
induce singlet oxygen production, morphological changes were observed (Figure 7 a-
c). The cell membranes of these treated cells appear damaged as confirmed by the 
propidium iodide staining of their nucleus (Figure 7b). Propidium iodide cannot bind to 
the nucleic acids of non-damaged cells since it is excluded by healthy cell membranes. 
The irradiated control cells, without nanoparticles loaded, show no staining with the 
propidium iodide (Figure 7d-f), indicating that the cells were viable. 
a) b) c)
d) e) f)
 
Figure 7. Bright field and fluorescence images of SK-BR-3 cells 8 min after irradiation, to 
produce singlet oxygen, and loaded with propidium iodide to stain dead cells: a – c) cells loaded 
with PR-AuNP-PEG-Ab conjugates and d – f) control cells without nanoparticles loaded. 
Images correspond to: bright field images (a and d); fluorescence images due to the 
fluorescence of the propidium iodide (b and e) and composite images of bright field and 
fluorescence (c and f). Only the SK-BR-3 cells following PDT with the PR-AuNP-PEG-Ab 
conjugates stained positive for propidium iodide (a – c). Scale bars = 20 µm. 
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CONCLUSIONS 
Treatment of cancer can be achieved in a targeting manner using ligands such as 
antibodies that are able to specifically recognise and bind to cell surface receptors 
expressed only on the cancer cell. Nanoparticles have recently emerged as ideal delivery 
vehicles in the treatment of cancer by PDT since they allow for the aqueous based 
delivery of hydrophobic photosensitizers and can be further used as platforms for the 
conjugation of targeting agents. Thus, nanoparticle conjugates can be used to selectively 
recognise tumour tissues and to treat them via photodynamic therapy.5,33 To the best of 
our knowledge, the synthesis and application of a water soluble gold nanoparticle-based 
conjugate that combines the functionalisation of gold nanoparticles with a porphyrin 
photosensitizer derivative, together with a PEG derivative ligand and an antibody for 
the targeted PDT of cancer cells has not been previously reported. In the work presented 
herein, a porphyrin derivative, PR-SH, together with a PEG derivative have been used 
to synthesise water soluble gold nanoparticles. When designing a conjugate to be used 
for PDT applications, a high production of singlet oxygen following irradiation of the 
photosensitizer is required. To date, different protocols have been reported for the 
synthesis of water soluble gold nanoparticles containing hydrophobic ligands including 
hydrophobic photosensitizers. In the research here presented, the gold nanoparticle 
conjugates were synthesised following two different protocols with the aim of 
determining the optimum method for targeted PDT applications. The first synthetic 
method was based on a biphasic method in which water and toluene were used as 
solvents and TOAB is used to enable the phase transfer of the reagents.10 This synthetic 
method yielded PR-AuNP-PEG (biphasic) of ca. 4.5 nm in diameter. The second 
synthetic method used a combination of DMF and THF as solvents which are miscible 
and therefore allowed the synthesis of the nanoparticles in a monophasic environment.22 
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The PR-AuNP-PEG (monophasic) were ca. 9 nm in diameter. Non-water soluble 
nanoparticles (PR-AuNP) containing the ligand PR-SH were also synthesised 
following the biphasic method for comparison. The free ligand and the synthesised 
nanoparticles were characterised using different spectroscopic techniques, UV-Vis 
absorption and fluorescence spectroscopies, together with transmission electron 
microscopy and zeta potential measurements. The results obtained from the 
spectroscopic characterisation confirmed the functionalisation of the nanoparticles with 
the porphyrin derivative ligand and, in combination with TEM results, allowed for an 
estimation of the porphyrin ligand per nanoparticle on each type of nanoparticles (56, 
3882 and 678 PR-SH/AuNP for PR-AuNP-PEG (biphasic), PR-AuNP-PEG 
(monophasic) and PR-AuNP, respectively). These results determined that those water 
soluble PR-AuNP-PEG nanoparticles synthesised using the monophasic method 
contained more porphyrin derivative ligands per nanoparticle than the nanoparticles 
synthesised following the biphasic method. The ability of the nanoparticles to produce 
singlet oxygen was investigated by measuring the maximum ratio of ADPA 
photobleaching following irradiation with blue light. The production of singlet oxygen 
by the porphyrin derivative ligand was enhanced when the ligand was attached to the 
surface of gold nanoparticles. The water insoluble particles containing only PR-SH, 
produced the highest level of singlet oxygen, since the production was measured in 
DCM where the lifetime of singlet oxygen is considerably longer than in comparison to 
aqueous media. Amongst the water soluble nanoparticles, the PR-AuNP-PEG 
(monophasic) produced higher levels of singlet oxygen than the PR-AuNP-PEG 
(biphasic), making those nanoparticle conjugates the optimal candidates for use in PDT. 
PR-AuNP-PEG (monophasic) were further covalently functionalised with the antibody 
anti-erbB2 to target the erbB2 receptors expressed on the surface of breast cancer SK-
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BR-3 cells with the aim of achieving targeted PDT. The PR-AuNP-PEG-Ab yielded a 
slightly lower % rate of ADPA photobleaching than the PR-AuNP-PEG (monophasic) 
in aqueous solution but had the advantage of containing a targeting agent for tumor 
selectivity. The PR-AuNP-PEG-Ab conjugates were used to induce the death of SK-
BR-3 breast cancer cells via PDT. The cells were incubated with the PR-AuNP-PEG-
Ab conjugates demonstrating a high level of cellular uptake. Following irradiation of 
the SK-BR-3 cancer cells incubated with the PR-AuNP-PEG-Ab conjugates, changes 
in the cellular morphology were observed and cell membrane damage was confirmed 
using staining with propidium iodide. The water soluble anti-erbB2 antibody-porphyrin 
conjugates reported in this work were shown to selectively target the erbB2 receptor 
that is overexpressed on SK-BR-3 breast cancer cells and are thus, ideal conjugates for 
the targeted PDT treatment of breast cancer cells. These results demonstrate that gold 
nanoparticle conjugates containing porphyrin derivatives as photosensitizers and 
antibodies as targeting agents covalently attached to PEG that provides water solubility 
may have a great potential for PDT of cancer. The research here reported will be 
extended further with the use of the nanoparticle-conjugates for in vivo treatment of 
breast cancer following PDT. Furthermore, by using different antibodies, similar 4-
component conjugates will be designed for targeting and treatment of various types of 
cancers.  
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SUPPLEMENTARY MATERIAL 
Supplementary material for this article is available in the online version. (1) Schematic 
representation of the PR-AuNP-PEG nanoparticle conjugates: gold nanoparticles 
functionalised with the thiolated porphyrin derivative ligand (red) and the thiolated 
polyethylene glycol derivative ligand (black) (Figure S1); (2) Schematic representation 
of the PR-AuNP conjugates: gold nanoparticles functionalised with the thiolated 
porphyrin derivative ligand (Figure S2); (3) a) Transmission electron micrograph and b) 
corresponding size distribution histogram of PR-AuNP (Figure S3); (4) a) UV-Vis 
absorption spectra of PR-SH at varying concentrations (from 0.5 to 15 μM) and b) 
resulting calibration curve plotting the absorbance at λ = 418 nm (Soret band) as a 
function of the concentration of PR-SH (Figure S4); (5) UV-Visible extinction spectra 
used to calculate the contribution of PR-SH to the extinction intensity of: a) PR-AuNP-
PEG (biphasic), b) PR-AuNP-PEG (monophasic) and c) PR-AuNP. To calculate the 
contribution of the ligands to the total extinction intensity (red lines), extinction 
intensity at  = 460 nm due to the AuNPs has to be subtracted from the total extinction 
intensity maximum for PR-AuNP-PEG and PR-AuNP (Figure S5); (6) Calculations 
for the concentration of PR-SH on the different functionalised nanoparticles: PR-
AuNP-PEG synthesised following the biphasic and the monophasic methods and PR-
AuNP (Figure S6); (7) Fluorescence excitation spectra of PR-SH (0.25 mM – black); 
PR-AuNP (blue); and PR-AuNP-PEG synthesised following the biphasic method (0.4 
mg/mL in water – green) and the monophasic method (0.4 mg/mL in water – red). The 
spectra of PR-SH and PR-AuNP were recorded using em/ex slits = 5 while the spectra 
of PR-AuNP-PEG were recorded using em/ex slits = 10. Inset: magnification of the 
fluorescence excitation spectra in the region between λ = 490 – 675 nm (Figure S7); (8) 
UV-Vis extinction spectrum of PR-AuNP-PEG-Ab in water (Figure S8); (9) Zeta 
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potential values of PR-AuNP-PEG and PR-AuNP-PEG-Ab. All of the measurements 
were performed in triplicate. The particles were dispersed in PBS (pH 7.4) (Table S1); 
(10) Time-dependent decay of ADPA absorption spectrum as a result of the 
photobleaching of the singlet oxygen probe upon irradiation of: a) PR-SH, b) PR-
AuNP, c) PR-AuNP-PEG (biphasic), d) PR-AuNP-PEG (monophasic) and e) PR-
AuNP-PEG-Ab in the presence of ADPA in DCM for PR-SH and PR-AuNP and in 
aqueous solution for PR-AuNP-PEG and PR-AuNP-PEG-Ab. The samples were 
irradiated for 4 h (3 h for PR-AuNP-PEG (biphasic)) with a blue light source (λ = 400 
– 500 nm) (Figure S9); (11) Percentage decay of ADPA photobleaching at λ = 378 nm 
following irradiation (400 – 500 nm) of: PR-SH (black line) PR-AuNP (red line), PR-
AuNP-PEG (biphasic) (green line), PR-AuNP-PEG (monophasic) (blue line) and PR-
AuNP-PEG-Ab (cyan line). The percentage decay of ADPA photobleaching for PR-
SH and PR-AuNP was performed in DCM while for PR-AuNP-PEG and PR-AuNP-
PEG-Ab the photobleaching was measured in an aqueous solution (Figure S10). 
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Figure S1. Schematic representation of the PR-AuNP-PEG nanoparticle conjugates: 
gold nanoparticles functionalised with the thiolated porphyrin derivative ligand (red) 
and the thiolated polyethylene glycol derivative ligand (black). 
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Figure S2. Schematic representation of the PR-AuNP conjugates: gold nanoparticles 
functionalised with the thiolated porphyrin derivative ligand. 
 
 
 
44 
 
a) b)
2 2.5 3 3.5 4 4.5 5 5.5 6 6.5 7 7.5
100
90
80
70
60
30
50
40
20
10
0
Diameter / nm
C
o
u
n
ts
 
 
Figure S3. a) Transmission electron micrograph and b) corresponding size 
distribution histogram of PR-AuNP. 
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Figure S4. a) UV-Vis absorption spectra of PR-SH at varying concentrations (from 
0.5 to 15 μM) and b) resulting calibration curve plotting the absorbance at  = 418 nm 
(Soret band) as a function of the concentration of PR-SH. 
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Figure S5. UV-Visible extinction spectra used to calculate the contribution of PR-
SH to the extinction intensity of: a) PR-AuNP-PEG (biphasic), b) PR-AuNP-PEG 
(monophasic) and c) PR-AuNP. To calculate the contribution of the ligands to the total 
extinction intensity (red lines), extinction intensity at  = 460 nm due to the AuNPs has 
to be subtracted from the total extinction intensity maximum for PR-AuNP-PEG and 
PR-AuNP. 
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PR-AuNP 
PR-SH concentration on AuNPs: 
 Abs = Abs418nm – Abs460nm 
Abs = 1.990 – 0.425 = 1.563 
Applying the calibration curved obtained 
in Figure S4:  
Abs = 0.0375 x CPR-SH – μM + 0.0095 
CPR-SH = 
0375.0
0095.0Abs
 
CPR-SH = 41.43 μM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S6. Calculations for the concentration of PR-SH on the different functionalised 
nanoparticles: PR-AuNP-PEG synthesised following the biphasic and the monophasic 
methods and PR-AuNP. 
 
 
 
PR-AuNP-PEG (biphasic) 
PR-SH concentration on AuNPs: 
 Abs = Abs430nm – Abs460nm 
Abs = 0.350 – 0.245 = 0.105 
Applying the calibration curved obtained 
in Figure S4:  
Abs = 0.0375 x CPR-SH – μM + 0.0095 
CPR-SH = 
0375.0
0095.0Abs
 
CPR-SH = 2.55 μM 
 
PR-AuNP-PEG (monophasic) 
PR-SH concentration on AuNPs: 
 Abs = Abs426nm – Abs460nm 
Abs = 0.820 – 0.186 = 0.634 
Applying the calibration curved obtained 
in Figure S4:  
Abs = 0.0375 x CPR-SH – μM + 0.0095 
CPR-SH = 
0375.0
0095.0Abs
 
CPR-SH = 16.65 μM 
48 
 
400 450 500 550 600 650
0
50
100
150
200
250
300
500 550 600 650
0
25
50
75
 
 
F
lu
o
re
s
c
e
n
c
e
 E
x
c
it
a
ti
o
n
 /
 a
.u
.
Wavelength / nm
 
 
F
lu
o
re
s
c
e
n
c
e
 E
x
c
it
a
ti
o
n
 /
 a
.u
.
Wavelength / nm
 
Figure S7. Fluorescence excitation spectra of PR-SH (0.25 mM – black); PR-AuNP 
(blue); and PR-AuNP-PEG synthesised following the biphasic method (0.4 mg/mL in 
water – green) and the monophasic method (0.4 mg/mL in water – red). The spectra of 
PR-SH and PR-AuNP were recorded using em/ex slits = 5 while the spectra of PR-
AuNP-PEG were recorded using em/ex slits = 10. Inset: magnification of the 
fluorescence excitation spectra in the region between  = 490 – 675 nm. 
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Figure S8. UV-Vis extinction spectrum of PR-AuNP-PEG-Ab in water. 
 
 
 
 
 
 
Table S1. Zeta potential values of PR-AuNP-PEG and PR-AuNP-PEG-Ab. All of 
the measurements were performed in triplicate. The particles were dispersed in PBS (pH 
7.4).  
 
 
 
 
 
 
Sample Zeta potential (mV) 
PR-AuNP-PEG 
(biphasic) 
-21.96 ± 1.0 
PR-AuNP-PEG 
(monophasic) 
-11.76 ± 0.3 
PR-AuNP-PEG-Ab 0.04 ± 0.1 
50 
 
320 340 360 380 400 420 440
0.2
0.4
0.6
0.8
 
 
E
x
ti
n
c
ti
o
n
Wavelength / nm
320 340 360 380 400 420 440
0.8
1.0
1.2
1.4
1.6
1.8
 
 
E
x
ti
n
c
ti
o
n
Wavelength / nm
320 340 360 380 400 420 440
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
 
 
E
x
ti
n
c
ti
o
n
Wavelength / nm
320 340 360 380 400 420 440
0.0
0.5
1.0
1.5
2.0
2.5
3.0
 
 
A
b
s
o
rb
a
n
c
e
Wavelength / nm
a) b)
c) d)
0h
4h
0h
4h
0h
4h
0h
3h
320 340 360 380 400 420 440
0.2
0.4
0.6
 
 
E
x
ti
n
c
ti
o
n
Wavelength / nm
e)
0h
4h
 
Figure S9. Time-dependent decay of ADPA absorption spectrum as a result of the 
photobleaching of the singlet oxygen probe upon irradiation of: a) PR-SH, b) PR-
AuNP, c) PR-AuNP-PEG (biphasic), d) PR-AuNP-PEG (monophasic) and e) PR-
AuNP-PEG-Ab, in the presence of ADPA in DCM for PR-SH and PR-AuNP, and in 
aqueous solution for PR-AuNP-PEG and PR-AuNP-PEG-Ab. The samples were 
irradiated for 4 h (3 h for PR-AuNP-PEG (biphasic)) with a blue light source ( = 400 
– 500 nm). 
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Figure S10. Percentage decay of ADPA photobleaching at  = 378 nm following 
irradiation (400 – 500 nm) of: PR-SH (black line) PR-AuNP (red line), PR-AuNP-
PEG (biphasic) (green line), PR-AuNP-PEG (monophasic) (blue line) and PR-AuNP-
PEG-Ab (cyan line). The percentage decay of ADPA photobleaching for PR-SH and 
PR-AuNP was performed in DCM while for PR-AuNP-PEG and PR-AuNP-PEG-Ab 
the photobleaching was measured in an aqueous solution. 
 
